Irvine, CA, United States of America

Melissa Gulmezian

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melissa Gulmezian: Innovator in Ophthalmic Compositions

Introduction

Melissa Gulmezian is a prominent inventor based in Irvine, California. She has made significant contributions to the field of ophthalmology through her innovative research and development. Her work focuses on creating advanced ophthalmic compositions that enhance therapeutic applications.

Latest Patents

Melissa holds a patent for "Ophthalmic compositions comprising polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers." This patent describes compositions and methods related to the ophthalmic use of these graft copolymers, highlighting their therapeutic uses. She has successfully developed a unique formulation that aims to improve patient outcomes in ophthalmic treatments.

Career Highlights

Melissa is currently employed at Allergan, Inc., a leading company in the pharmaceutical industry known for its focus on eye care products. Her role at Allergan allows her to leverage her expertise in developing innovative solutions for ophthalmic applications. With her dedication and skill, she has established herself as a valuable asset to her team.

Collaborations

Some of her notable coworkers include Anuradha V Gore and Chetan Pujara. Their collaborative efforts contribute to the advancement of research and development in the field of ophthalmology.

Conclusion

Melissa Gulmezian's contributions to ophthalmic compositions demonstrate her commitment to innovation and improving healthcare solutions. Her work continues to impact the field positively, showcasing the importance of research and development in advancing medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…